Top Biotechnology companies in United Kingdom by Total Assets

This ranking features the top 47 Biotechnology companies in United Kingdom ranked by Total Assets, totaling a Total Assets of USD 204.56 B, for June 26, 2025.

#	Name	Market Capitalization Share Price Year-To-Date (YTD) return Price to Earnings Ratio (P/E) Revenue EBIT EBITDA Net Income Free Cash Flow Dividend Yield Free Cash Flow Yield Total Liabilities Cash and Short-Term Investments	Stock Price	Change	Price (30 days)	52W low/high	Sector

Items per page

Frequently Asked Questions

Which Biotechnology company in United Kingdom has the highest Total Assets ?

The Biotechnology company in United Kingdom with the highest Total Assets is AstraZeneca PLC (LSE: AZN.L) at USD 104.03 B.
Which Biotechnology company in United Kingdom has the lowest Total Assets ?

The Biotechnology company in United Kingdom with the lowest Total Assets is ImmuPharma plc (LSE: IMM.L) at None.

What are the top 10 Biotechnology companies in United Kingdom by Total Assets ?

The top 10 Biotechnology companies in United Kingdom by Total Assets are AstraZeneca PLC, GSK plc, Smith & Nephew plc, Roivant Sciences Ltd., ConvaTec Group Plc, LivaNova PLC, Immunocore Holdings plc, Autolus Therapeutics plc, Centessa Pharmaceuticals plc and Benchmark Holdings plc.
What are the bottom 10 Biotechnology companies in United Kingdom by Total Assets ?

The bottom 10 Biotechnology companies in United Kingdom by Total Assets are ImmuPharma plc, Fusion Antibodies plc, Hemogenyx Pharmaceuticals Plc, genedrive plc, Akari Therapeutics, Plc, Cizzle Biotechnology Holdings Plc, Bicycle Therapeutics plc, Futura Medical plc, Bioventix PLC and NIOX Group Plc.